Nothing Special   »   [go: up one dir, main page]

SI1893237T1 - Farmacevtska zmes ki vsebuje organopolisiloksan elastomer in učinkovino v obliki raztopine - Google Patents

Farmacevtska zmes ki vsebuje organopolisiloksan elastomer in učinkovino v obliki raztopine

Info

Publication number
SI1893237T1
SI1893237T1 SI200630410T SI200630410T SI1893237T1 SI 1893237 T1 SI1893237 T1 SI 1893237T1 SI 200630410 T SI200630410 T SI 200630410T SI 200630410 T SI200630410 T SI 200630410T SI 1893237 T1 SI1893237 T1 SI 1893237T1
Authority
SI
Slovenia
Prior art keywords
organopolysiloxane elastomer
pharmaceutical composition
active principle
solubilized active
solubilized
Prior art date
Application number
SI200630410T
Other languages
English (en)
Inventor
Nathalie Barthez
Emilie Tonglet
Sandrine Orsoni
Laurent Fredon
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of SI1893237T1 publication Critical patent/SI1893237T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI200630410T 2005-06-17 2006-06-15 Farmacevtska zmes ki vsebuje organopolisiloksan elastomer in učinkovino v obliki raztopine SI1893237T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0506183A FR2887150B1 (fr) 2005-06-17 2005-06-17 Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
EP06778599A EP1893237B1 (fr) 2005-06-17 2006-06-15 Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise

Publications (1)

Publication Number Publication Date
SI1893237T1 true SI1893237T1 (sl) 2010-03-31

Family

ID=35559477

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200630410T SI1893237T1 (sl) 2005-06-17 2006-06-15 Farmacevtska zmes ki vsebuje organopolisiloksan elastomer in učinkovino v obliki raztopine

Country Status (15)

Country Link
US (1) US20080194528A1 (sl)
EP (1) EP1893237B1 (sl)
JP (1) JP2008543815A (sl)
AT (1) ATE442864T1 (sl)
BR (1) BRPI0613276A2 (sl)
CA (1) CA2611869A1 (sl)
CY (1) CY1109507T1 (sl)
DE (1) DE602006009259D1 (sl)
DK (1) DK1893237T3 (sl)
ES (1) ES2331811T3 (sl)
FR (1) FR2887150B1 (sl)
PL (1) PL1893237T3 (sl)
PT (1) PT1893237E (sl)
SI (1) SI1893237T1 (sl)
WO (1) WO2006134272A1 (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
EP1917072B1 (en) 2005-06-01 2013-02-27 Stiefel Research Australia Pty Ltd Vitamin formulation
EP2167036B1 (en) * 2007-07-11 2013-09-18 Dow Corning Corporation Compositions for delivering a drug
JP6002385B2 (ja) * 2008-09-12 2016-10-05 クリティカル ファーマシューティカルズ リミテッドＣｒｉｔｉｃａｌ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｉｍｉｔｅｄ 医薬組成物、医薬組成物における吸収促進剤の使用方法、及び医薬組成物の製造方法
JP2012513387A (ja) * 2008-12-23 2012-06-14 ガルデルマ・ソシエテ・アノニム 感水性の活性成分を含む、局所用医薬組成物
US20100322875A1 (en) 2009-06-18 2010-12-23 Advanced Bio-Technologies, Inc. Silicone scar treatment preparation
GB0919650D0 (en) 2009-11-10 2009-12-23 Futura Medical Developments Ltd Pharmaceutical composition
MX2012007229A (es) * 2009-12-22 2012-07-30 Leo Pharma As Composicion cutanea que comprende analogo de vitamina d y mezcla de solvente y tensioactivos.
US20130023501A1 (en) * 2009-12-22 2013-01-24 Leo Pharma A/S Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3943248A (en) * 1974-11-04 1976-03-09 Shulman Max J Methods of treating burns using colophony containing preparations
FR2719220A1 (fr) * 1994-04-29 1995-11-03 Lafon Labor Nouvelle forme galénique pour l'administration transdermique.
US6538039B2 (en) * 1994-04-29 2003-03-25 Laboratoire L. Lafon Pharmaceutical dosage form for transdermal administration
FR2740038B1 (fr) * 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
US6103250A (en) * 1999-07-06 2000-08-15 Revlon Consumer Products Corporation Anhydrous cosmetic compositions containing emulsifying siloxane elastomer
US6924400B2 (en) * 2001-12-10 2005-08-02 Galderma Research & Development, Snc Triaromatic vitamin D analogues
ES2275106T3 (es) * 2002-08-27 2007-06-01 GALDERMA RESEARCH & DEVELOPMENT, S.N.C. Analogos de la vitamina d.
FR2843962B1 (fr) * 2002-08-27 2005-12-02 Galderma Res & Dev Analogues de la vitamine d
WO2004028515A1 (en) * 2002-09-26 2004-04-08 Young-Kweon Choi Matrix type patch for transdermal administration of vitamin d analog and the use thereof
BRPI0406490A (pt) * 2003-02-05 2005-12-06 Galderma Res & Dev Composições, composição cosmética ou dermatológica e uso de uma composição
RU2006121973A (ru) * 2003-11-21 2007-12-27 Галдерма Ресерч Энд Девелопмент, С.Н.С. (Fr) Распыляемая композиция для введения производных витамина d
FR2871695B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises

Also Published As

Publication number Publication date
BRPI0613276A2 (pt) 2010-12-28
CA2611869A1 (fr) 2006-12-21
DE602006009259D1 (de) 2009-10-29
PT1893237E (pt) 2009-11-03
FR2887150B1 (fr) 2007-08-03
PL1893237T3 (pl) 2010-02-26
CY1109507T1 (el) 2014-08-13
WO2006134272A1 (fr) 2006-12-21
JP2008543815A (ja) 2008-12-04
DK1893237T3 (da) 2009-11-09
EP1893237B1 (fr) 2009-09-16
ATE442864T1 (de) 2009-10-15
ES2331811T3 (es) 2010-01-15
FR2887150A1 (fr) 2006-12-22
EP1893237A1 (fr) 2008-03-05
US20080194528A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
SI1893237T1 (sl) Farmacevtska zmes ki vsebuje organopolisiloksan elastomer in učinkovino v obliki raztopine
TW200744661A (en) Topical cosmetic formulations for regulating and improving the moisture content of the skin
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
EP2144590A4 (en) TREATMENT COMPOSITIONS FOR THE SKIN AND METHODS
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
HK1075617A1 (en) Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis
MY143795A (en) Tetrahydropyridoindole derivatives
RS51569B (en) COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL
MX2009005308A (es) Composiciones que comprenden peroxido de benzoilo, al menos un derivado del acido naftoico y al menos un compuesto del tipo polimeros de poliuretano o derivados de estos y sus usos.
MX2010003258A (es) Utilizacion de un nuevo agente natural en composiciones cosmeticas.
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
CO5640037A2 (es) Derivados de la quinazolina para el tratamiento del cancer
ES2267706T3 (es) Agentes como la nicotinamida o cardr para el tratamiento de trastornos de la piel.
MX2008003422A (es) Composiciones que comprenden al menos un derivado de acido naftoico y al menos un compuesto de tipo polimero de poliuretano o derivados del mismo, procesos de preparacion y composiciones que comprenden al menos un derivado de acido naftoico y al meno
BRPI0512357A (pt) composições compreendendo estrÈncio e vitamina d e usos destas
TNSN07203A1 (en) Pharmaceutical compositions for the treatment of cellulite
MXPA05014184A (es) Utilizacion de acido hialuronico para la preparacion de composiciones para el tratamiento de aftas en la cavidad oral.
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
ATE399558T1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
ES2325291A1 (es) "uso de un extracto de silybum marianum"
HK1111924A1 (en) Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient
SE0203817D0 (sv) New composition
MX2009001631A (es) Formulacion farmaceutica para el tratamiento de afecciones en la piel.
DK1620116T3 (da) Anvendelse af cinchona til fremstilling af et l gemiddel, som stimulerer angiogenese
BR0215498A (pt) Composição farmacêutica compreendendo uma glitazona e um ácido 4-oxobutanóico e o seu uso para o tratamento de diabetes